RHYTHM PHARMACEUTICALS CEO David P. Meeker exercised Options for 50,000 shares at $6.05 per share on 2026-09-14. He then sold 50,000 shares across five transactions priced from $101.75 to $105.19, leaving 239,258 shares, while a derivative-security holding stood at 15,431. The sequence changed his reported holdings.
Key Highlights
- David P. Meeker sold 50,000 RHYTHM PHARMACEUTICALS shares across five transactions priced from $101.75 to $105.19 per share.
- Meeker held 239,258 RHYTHM PHARMACEUTICALS shares after the sales.
- His derivative-security holding stood at 15,431 after the option exercise, representing about 76.4% of his prior holding.
RHYTHM PHARMACEUTICALS, INC. (NASDAQ: RYTM) CEO David P. Meeker exercised options for 50,000 shares at $6.05 per share on 14 September 2026. The transaction was followed by sales of the same number of shares across five transactions at prices ranging from $101.75 to $105.19 per share.
The option exercise carried transaction code M. Meeker’s share ownership reached 289,258 after that transaction, and the exercise represented about 17.3% of his resulting share holding. The subsequent sales carried transaction code S. After those transactions, Meeker owned 239,258 RHYTHM PHARMACEUTICALS shares.
Derivative Securities and Reported Holdings
The transaction records also show an exercise involving 50,000 derivative securities. Meeker held 15,431 derivative securities after that transaction. The exercised amount represented about 76.4% of his prior derivative-securities holding. The transaction codes used here mean: M denotes the exercise or conversion of a derivative security; S denotes an open-market or private sale.
FAQs
Q: What did the RHYTHM PHARMACEUTICALS CEO exercise?
A: David P. Meeker exercised options for 50,000 shares of RHYTHM PHARMACEUTICALS. The exercise was carried out at $6.05 per share on 14 September 2026.
Q: How many RHYTHM shares did David Meeker sell?
A: Meeker sold 50,000 RHYTHM PHARMACEUTICALS shares across five transactions. The filing reports these transactions on 14 September 2026, with sale prices ranging from $101.75 to $105.19 per share.
Q: What was David Meeker’s RHYTHM share holding afterward?
A: Meeker owned 239,258 RHYTHM PHARMACEUTICALS shares after the five sales. His derivative-security holding stood at 15,431 after the option exercise.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.